EFFICACY OF NEWER GLP-1 RECEPTOR AGONISTS ON NON-ALCOHOLIC FATTY LIVER DISEASE IN TYPE 2 DIABETES. RMSR. 2025;3(5):290-294. Accessed August 7, 2025. https://medscireview.net/index.php/Journal/article/view/1109